LoDoCo2
Low-dose colchicine for secondary prevention of cardiovascular disease – LoDoCo2 trial
- Stage
- klaar
- Medicine
- colchicine
- Population
- ASCVD
- Phase
- III
- First Patient In
- 24 November 2016
- Last Patient In
- 3 December 2018
- Last Patient Last Visit
- 14 February 2020
National Lead
prof. dr. J.H. Cornel
Cardioloog
Study Director
